` Comparison: 688506, NOVO B - Alpha Spread

S
688506
vs
NOVO B

Over the past 12 months, Sichuan Biokin Pharmaceutical Co Ltd has significantly outperformed NOVO B, delivering a return of +97% compared to the NOVO B's 50% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
688506
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

S
Intrinsic Value
12.69 CNY
Overvaluation 96%
Intrinsic Value
Price
NOVO B Intrinsic Value
644.94 DKK
Undervaluation 30%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
315 CNY
Novo Nordisk A/S
CSE:NOVO B
451.15 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
688506, NOVO B

688506
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
S
Sichuan Biokin Pharmaceutical Co Ltd
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
688506, NOVO B

688506
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

Sichuan Biokin Pharmaceutical Co Ltd
41.9%
NOVO B
84.3%

Operating Margin

Sichuan Biokin Pharmaceutical Co Ltd
-447.4%
NOVO B
44.6%

Net Margin

Sichuan Biokin Pharmaceutical Co Ltd
-427.3%
NOVO B
34.5%

FCF Margin

Sichuan Biokin Pharmaceutical Co Ltd
-447%
NOVO B
24.5%

ROE

Sichuan Biokin Pharmaceutical Co Ltd
-40.5%
NOVO B
88.1%

ROA

Sichuan Biokin Pharmaceutical Co Ltd
-26.1%
NOVO B
26.6%

ROIC

Sichuan Biokin Pharmaceutical Co Ltd
-247.6%
NOVO B
30.4%

ROCE

Sichuan Biokin Pharmaceutical Co Ltd
-36.8%
NOVO B
70%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
688506, NOVO B

Loading
688506
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
688506, NOVO B

Loading
688506
NOVO B
Difference
www.alphaspread.com

Performance By Year
688506, NOVO B

Loading
688506
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 688506 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account